Health Care & Life Sciences » Pharmaceuticals | Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical Co. Ltd.

Kaken Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY445.79
Market Cap
JPY201.72 B
Shares Outstanding
45.94 M
Public Float
28.99 M

Profile

Address
2-28-8 Honkomagome
Tokyo Tokyo 113
Japan
Employees -
Website http://www.kaken.co.jp
Updated 07/08/2019
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the following business divisions: Pharmaceuticals and Medical Devices, Agrochemicals and Animal Health Products, Overseas Activity, Research & Development, and Licensing Opportunities. The Pharmaceuticals and Medical Devices division offers artz(anti-osteoarthritis), clenafin (topical onychomycosis treatment product), seprafilm (anti-adhesive absorbent barrier), lipidil (anti-hyperlipidemia product), fiblast spray (wound-healing product), mentax (anti-trichophyton product) and generic drugs.

Financials

View All

Tetsuo Onuma
President & Representative Director
Chikara Ieda
Director, General Manager-Research & Development